Department of Neuroradiology, Mayo Clinic, Rochester, Minnesota 55905, USA.
AJNR Am J Neuroradiol. 2012 Mar;33(3):535-40. doi: 10.3174/ajnr.A2815. Epub 2011 Dec 15.
Localization of spinal CSF leaks in CSF hypovolemia is critical in directing focal therapy. In this retrospective review, our aim was to determine whether GdM was helpful in confirming and localizing spinal CSF leaks in patients in whom no leak was identified on a prior CTM.
Forty-one symptomatic patients with clinical suspicion of SIH were referred for GdM after undergoing at least 1 CTM between February 2002 and August 2010. A retrospective review of the imaging and electronic medical records was performed on each patient.
In 17 of the 41 patients (41%), GdM was performed for follow-up of a previously documented leak at CTM. In the remaining 24 patients (59%), in whom GdM was performed for a suspected CSF leak, which was not identified on CTM, GdM localized the CSF leak in 5 of 24 patients (21%). In 1 of these 5 patients, GdM detected the site of leak despite negative findings on brain MR imaging, spine MR imaging, and CTM of the entire spine. Sixteen of 17 patients with previously identified leaks underwent interval treatment, and leaks were again identified in 12 of 17 (71%).
GdM is a useful technique in the highly select group of patients who have debilitating symptoms of SIH, a high clinical index of suspicion of spinal CSF leak, and no demonstrated leak on conventional CTM. Intrathecal injection of gadolinium contrast remains an off-label use and should be reserved for those patients who fail conventional CTM.
在 CSF 低容量性低颅压患者中,准确定位脊髓 CSF 漏对于靶向治疗至关重要。在这项回顾性研究中,我们旨在确定钆增强磁共振脊髓造影(GdM)是否有助于确认和定位在先前 CTM 检查未发现漏口的患者的脊髓 CSF 漏。
2002 年 2 月至 2010 年 8 月期间,41 例有临床症状怀疑为自发性颅内低压(SIH)的患者在至少接受 1 次 CTM 检查后被转介进行 GdM。对每位患者的影像学和电子病历进行回顾性分析。
在 41 例患者中(41%),17 例因先前 CTM 检查发现漏口而进行 GdM 随访;在其余 24 例(59%)因疑似 CTM 检查未发现漏口的患者中,GdM 定位了 5 例(21%)的 CSF 漏口。在这 5 例患者中,有 1 例尽管脑 MRI、脊柱 MRI 和全脊柱 CTM 检查均未见漏口,但 GdM 仍发现了漏口。17 例先前发现漏口的患者中有 16 例接受了间隔期治疗,在这 16 例患者中,12 例(71%)再次发现漏口。
GdM 是一种有用的技术,适用于有以下情况的高度选择患者:有症状严重的 SIH、高临床可疑性脊柱 CSF 漏和常规 CTM 未发现漏口。鞘内注射钆对比剂仍然是一种超适应证使用,应保留给那些常规 CTM 检查失败的患者。